搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
LancasterOnline
8 小时
Gov. Josh Shapiro touts tax cuts, investing in small businesses during stop in Lancaster city
On a stop in Lancaster city, Gov. Josh Shapiro said Pennsylvania intends to follow through with its $21 million commitment to ...
财富中文网
14 小时
葛兰素史克首席数字与技术官:不想把公司变成谷歌
肖比·拉玛克里希南早期职业生涯的大部分时间都在硅谷度过。作为葛兰素史克(GSK)的首席数字与技术官(CDTO),拉玛克里希南在苹果(Apple)和赛富时(Salesforce)等科技巨头工作了多年,后来转向日益技术化的制药行业。
LancasterOnline
1 天
Shapiro touts tax cuts, investing in small businesses during stop in Lancaster city
GSK plans to invest $800 million over the next four years in an expansion project ... These investments are not just about ...
2 天
on MSN
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has ...
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
Bisnow
6 天
Big Pharma Tweaks Real Estate Strategy As $200B Patent Cliff Approaches
With that in mind, GSK is partnering with developer Reef and investor UBS Asset Management to build a 1.4M SF, £900M life ...
Zawya
6 天
Sweid & Sweid awards construction contract for AED 730mln project, Sweid One, to Dutco ...
Sweid One is a pivotal project for us, designed to raise the bar for commercial office space within JLT,” said Maher Sweid, ...
6 天
Investors can start building towards a £10k second income with just £5 a day!
A fiver a day seems like a small price to pay for a potentially lucrative second income later in life. But patience and ...
Pharmabiz
7 天
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic ...
US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...
stockhead
8 天
Health Check: Can Syntara produce the next multibillion-dollar Aussie blood cancer drug?
Syntara hopes to emulate the success of Ojjaara, a $2.6 billion home-grown myelofibrosis therapy approved in the US.
Real Madrid CF
9 天
Real Madrid Foundation and GSK have renewed their agreement to promote health and social ...
The collaboration has positively impacted children with neuromuscular and respiratory conditions since 2018, as well as ...
BioPharma Dive
13 天
GSK taps a startup for shot at Alzheimer’s drug
The collaboration deal, which could be worth hundreds of millions of dollars, is a “pivotal moment” for Muna Therapeutics, a ...
FierceBiotech
13 天
Atlas unveils a new $450M fund targeted at biotechs 2 years after its last
Massachusetts-based VC shop Atlas Venture has drawn together another $450 million fund to be channeled toward innovative ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈